http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
( Soo Ick Cho ),( Jaewon Lee ),( Jin Lim ),( Jong Seo Park ),( Miso Kim ),( Tae-yong Kim ),( Tae Min Kim ),( Kyung-hun Lee ),( Bhumsuk Keam ),( Sae-won Han ),( Je-ho Mun ),( Kwang Hyun Cho ),( Seong J 대한피부과학회 2017 대한피부과학회 학술발표대회집 Vol.69 No.2
Background: Pruritus is very common symptom in patients under anti-cancer therapy. However, the characteristics of pruritus according to anti-cancer agents have not been known well. Objectives: To ascertain the characteristics of pruritus induced by targeted anti-cancer agents using a questionnaire-based survey. Methods: Questionnaires included numerical rating scale (NRS) for itching, 5-D itch scale and skin dryness. Medical records of anticancer treatment, including cancer types and types of anticancer agents, were reviewed. Results: Total 374 cancer patients finished the survey, of which 107 (28.6%) were treated with targeted therapy. Two hundreds and five (54.8%) patients had pruritus, of which 65 (31.7%) were under targeted therapy. Epidermal growth factor receptor inhibitors (EGFRIs) users showed highest prevalence of itching (77.3%) and score of NRS for itching. 5-D itch score was also highest in subjects of EGFRIs, particularly in items of duration, degree, disability and distribution. Patients of EGFRIs showed high prevalence of itching on face, chest, buttocks and upper arms. Skin dryness in EGFRIs showed strongest relationship with 5-D itch scale score. Conclusion: Patients receiving EGFRIs suffered from pruritus frequently and severely. They not only experienced long-lasting and intense itching causing sleep discomfort, also had specific body sites of itching. Clinicians should pay attention to unusual features of itching according to types of targeted therapy.
Congenital Dermal Melanocytosis on the Foot: A Case Report and Review of the Literature
( Soo Ick Cho ),( Jungyoon Moon ),( Gwanghyun Jo ),( Cheol Lee ),( Je-ho Mun ) 대한피부과학회 2019 Annals of Dermatology Vol.31 No.2
Dermal melanocytosis is a common pigmented skin disease, characterized by an increased number of ectopic melanocytes in the dermis. Rare variants of dermal melanocytosis that do not belong to these four typical groups―nevus of Ota, nevus of Ito, blue nevus, and Mongolian spots―are called dermal melanocyte hamartoma, or congenital dermal melanocytosis (CDM) as it mostly appears from birth. We report a case of CDM on the foot of a young woman with a literature review of previously reported cases of CDM. (Ann Dermatol 31(2) 213∼216, 2019)